{"id":"energi-f703-gel","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"The drug delivers bioactive factors in a gel matrix to the wound site, promoting angiogenesis, collagen deposition, and epithelialization. The gel formulation provides sustained release and maintains a moist wound environment conducive to healing. This approach aims to accelerate closure of chronic or difficult-to-heal wounds.","oneSentence":"ENERGI-F703 is a topical gel formulation designed to promote wound healing and tissue regeneration through growth factor delivery.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:11:02.408Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Chronic wounds and ulcers (diabetic foot ulcers, pressure ulcers, venous leg ulcers)"}]},"trialDetails":[{"nctId":"NCT05930210","phase":"PHASE3","title":"A Study to Evaluate ENERGI-F703 GEL in Diabetic Foot Ulcer","status":"RECRUITING","sponsor":"Energenesis Biomedical Co., Ltd.","startDate":"2023-05-30","conditions":"Diabetic Foot Ulcer, Foot Ulcer, Diabetes Mellitus","enrollment":230},{"nctId":"NCT04078555","phase":"PHASE2","title":"A Study to Evaluate ENERGI-F703 GEL in Venous Leg Ulcer","status":"UNKNOWN","sponsor":"Energenesis Biomedical Co., Ltd.","startDate":"2022-07-26","conditions":"Venous Leg Ulcer","enrollment":80}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"ENERGI-F703 GEL","genericName":"ENERGI-F703 GEL","companyName":"Energenesis Biomedical Co., Ltd.","companyId":"energenesis-biomedical-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"ENERGI-F703 is a topical gel formulation designed to promote wound healing and tissue regeneration through growth factor delivery. Used for Chronic wounds and ulcers (diabetic foot ulcers, pressure ulcers, venous leg ulcers).","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}